The capital markets have seen a significant jump in liquidity over the past 24 months, driven in part by an increase in foreign portfolio inflows. However, domestic investors have played a growing role as the markets continue to rebound from the 2008 sell-off crisis (see analysis). This is in part a reflection of a return by retail investors, but it...
Frontier markets gained popularity amongst foreign investors before the global financial crisis of 2009. These countries’ economic prospects were improving and more so, the level of liquidity in the global economy encouraged investors to take risks. These markets were recognised as the next generation of emerging markets, less established than...
THE COMPANY: Fidson Healthcare is a wholly indigenous pharmaceuticals company and a member of the Fidson Group. It is one of the leading pharmaceuticals firms in Nigeria and the West African sub-region. The company, which was formed in 1995, manufactures, markets and exports high-quality pharmaceuticals...
THE COMPANY: Dangote Cement is a fully integrated cement company with projects and operations in Nigeria, Benin and Ghana. Cement was the initial focus of the Dangote Group’s trading operations in 1981. Since that time, the larger conglomerate has made strides to transition from a trader of cement to a...
In what way will the new corporate governance metrics and rankings influence investor behaviour?
The latest international bond sale from Nigeria, which was heavily oversubscribed, underscored the bullishness of overseas investors regarding the country’s sustained if uneven growth. However, the yield level on the offering also highlights the looming challenges that Nigeria, along with other emerging markets, could face when seeking to raise...
Stay updated on how some of the world’s most promising markets are being affected by the Covid-19 pandemic, and what actions governments and private businesses are taking to mitigate challenges and ensure their long-term growth story continues.
Register now and also receive a complimentary 2-month licence to the OBG Research Terminal.
Register Here×